Of phages and men

phage 281Of phages and men

Of phages and men

Attachment of a bacteriophage on a bacterium

Attachment of a bacteriophage on a bacterium

Just after the discovery in 1917 by Felix d’Hérelle of bacteriophages, the natural-born killers of bacteria, their use have been rapidly recognized by a large number of scientists as a possible way to cure bacterial infections. In 1919, a first patient was cure for diphtheria using bacteriophages. Phagotherapy was born! Phages infect specifically bacteria letting safe patient’s cells. More explanations in picture

George Eliava, a georgian microbiologist, founds in 1923 at Tbilissi, Georgia, a institute of virology where he studies from 1930 bacteriophages and the application of phagotherapy for the Soviet Union. From that time, the use of bacteriophages to cure remains a common practice in Georgia that is nowadays subjected to important health tourism.

Since the advent of antibiotics in 1940, phagotherapy falls utterly in disuse. Coming back on stage in Europe during the seventies, phagotherapy appears today as a promising alternative way to fight multidrug-resistant bacteria that are notably responsible for nosocomial infections. The challenge of this therapy is to get it over with multidrug-resistant bacteria in turning phages into a new drug. Indeed, since a couple of years, the resistance of antibiotic and the lack of development towards new treatments to cure bacterial infections are responsible for a growing number of therapeutic deadlocks. Today, it is estimated that more than 12,000 deaths are due to antibiotics resistances.

In this health context, Pherecydès Pharma has call out Clean Cells for the manufacturing of phages cocktail batches dedicated to the treatment of badly burned patients and Clean Cells has came forward and took up this challenge. It’s taking on the manufacturing and the quality control of these phages for a therapeutic use within the frame of the European collaborative project Phagoburn that Clean Cells initiates phagotherapy. Today, a clinical trial is currently being carried out (to treat about a hundred patients suffering from skin burns with a definite risk of surinfection with bacteria).

Also, thanks to the authorization to produce experimental drugs in compliance with good manufacturing practice (GMP), Clean Cells, as an authorized pharmaceutical facility, is now in position to offer its customers a wide panel of services for drug manufacturing as well as for biosafety throughout the whole manufacturing process, as depicted in the following scheme:

Clean Cells Phage

To learn more about our production and quality control capabilities , please contact Audrey Larrieu, head of production, at 02 51 09 27 40 or by email: alarrieu@clean-cells.com

Replay the Laurent Bretaudeau’s lecture, R&D director at Clean Cells, at the EMA Workshop on the therapeutic use of bacteriophages (London, 8 June 2015)

 

Catalogue Test

Our News & Events

  • Boost Your Brain

    “Boost your Brain” aim at providing information to our personnel about diverse topics concerning the biopharmaceutical field…

  • Clean Cells’ Events

    In the third quarter, join the Clean Cells’ team at : Regmed Europe and NLSDays

  • Clean Cells’ Events

    Meet with Clean Cells. In the first quarter, join the Clean Cells’ team at the Centennial Celebration of Bacteiophage research…

  • Clean Cells’ Events

    Meet with Clean Cells. In the first quarter, join the Clean Cells’ team at :
    BIOTECH SHOWCASE 2017…

  • Clean Cells’ Events

    Meet with Clean Cells. In the fourth quarter, join the Clean Cells’ team at :
    WORLD VACCINE CONGRESS…

  • Clean Cells’ Events

    In the third quarter, join the Clean Cells’ team at : ANTIBODY INDUSTRIAL SYMPOSIUM, EMBO CONFERENCE, BIOREGATE FORUM…

  • Clean Cells’ Newsletter

    Clean Cells is doing every to propose solutions that allow them to follow daily its activities. This is the reason why…

  • Of phages and men

    Clean Cells, as an authorized pharmaceutical facility, is now in position to offer its customers a wide panel of services for drug…

  • Clean Cells Tunes into Gene Therapy

    Clean Cells expands its service portfolio by tuning into gene therapy products since the beginning of 2015…

  • Clean Cells joins Come In Vendée

    Artists, merchants and companies from the Vendée that will unit to participate to the next Vendée Globe?…

  • Clean Cells’ Events

    In the second quarter, join the Clean Cells’ team at

  • Phage Therapy

    The Lancet ID published in november, 2015, a publication about PhagoBurn project, called “Phage therapy for severe infections…

  • ESGCT, Helsinki – Finland

    Dr Arnold Van der Luit will be attending the ESGCT (European Society of Gene and Cell Therapy), in Helsinki, Finland…

  • Workshop bacteriophages

    On 8 June 2015, the European Medicines Agency organized a workshop on the therapeutic use of bacteriophages…

  • Clean Cells’ New Office

    We are thus pleased to announce that we are setting up an new office in London, UK…